Aliskiren Effect on Plaque Progression in Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double-Blind Placebo-Controlled Trial

BACKGROUND: The renin–angiotensin system is well recognized as a mediator of pathophysiological events in atherosclerosis. The benefits of renin inhibition in atherosclerosis, especially when used in combination with angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEIs/ARBs)...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Mihai, Georgeta, Varghese, Juliet, Kampfrath, Thomas, Gushchina, Liubov, Hafer, Lisa, Deiuliis, Jeffrey, Maiseyeu, Andrei, Simonetti, Orlando P., Lu, Bo, Rajagopalan, Sanjay
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2013
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3698800/
https://ncbi.nlm.nih.gov/pubmed/23686372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.112.004879
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items